Team
Portfolio

medium-logo
Peers amongst entrepreneurs
Thomas’ strategic perspective on product roadmap and Alex’ support on go-to-market made the difference.
Alex Igelsböck • CEO & Founder Adverity
We really wanted a seed stage SaaS VC with entrepreneurial background and 42CAP was our first choice.
Gregor Stühler • CEO & Founder Scoutbee
Alex was my core advisor as an entrepreneur for structuring and negotiating my Series A.
Ben Askew-Renaut • CEO & Founder Packlink
42CAP is the ideal partner to build a global SaaS business.
Kristjan Vilosius • CEO & Founder Katana
42CAP had a conviction in the Gig Economy, which intrigued us.
Nicolas Rebout • CEO & Founder Shine
Focus
We initially invest € 0.5 to 2m in seed-stage tech- and data-driven B2B software companies across Europe with global ambition. Feel free to read our detailed investment thesis.
Background
We are seasoned entrepreneurs turned investors. With Hybris and eCircle we previously built two of Europe's largest B2B software companies culminating in $1.6b cash exits to SAP and Teradata respectively.
Approach
We aim to be the investors we wished we had back then as founders: Contributing the product- and go-to-market experience we've garnered as founders and later senior executives to help scale B2B software companies through all stages. And be sparring partners in developing the founders.
Team
Thomas
Wilke

Alex
Meyer

Moritz Zimmermann

Julian
von Fischer

Companies

Companies

News
More on Medium
Why We Invested in emporix
Thomas Wilke
Close-up: Read Through - The end of bookkeeping
Alex Meyer
Exit: Taking Entrepreneurship into account
Thomas Wilke
Close-up: Transatlantic advance into digital pain therapy
Alex Meyer
VenturePoland Podcast: Looking for a Better VC Partner
Julian von Fischer
Close-up: The last bastion, the intelligent production
Thomas Wilke
Why We Invested in emporix
Thomas Wilke
Close-up: Read Through - The end of bookkeeping
Alex Meyer
Exit: Taking Entrepreneurship into account
Thomas Wilke
Close-up: Transatlantic advance into digital pain therapy
Alex Meyer
VenturePoland Podcast: Looking for a Better VC Partner
Julian von Fischer
Close-up: The last bastion, the intelligent production
Thomas Wilke
Why We Invested in emporix
Thomas Wilke
Close-up: Read Through - The end of bookkeeping
Alex Meyer
Exit: Taking Entrepreneurship into account
Thomas Wilke
Close-up: Transatlantic advance into digital pain therapy
Alex Meyer
VenturePoland Podcast: Looking for a Better VC Partner
Julian von Fischer
Close-up: The last bastion, the intelligent production
Thomas Wilke
Why We Invested in emporix
Thomas Wilke
Close-up: Read Through - The end of bookkeeping
Alex Meyer
Exit: Taking Entrepreneurship into account
Thomas Wilke
Close-up: Transatlantic advance into digital pain therapy
Alex Meyer
VenturePoland Podcast: Looking for a Better VC Partner
Julian von Fischer
Close-up: The last bastion, the intelligent production
Thomas Wilke
Why We Invested in emporix
Thomas Wilke
Close-up: Read Through - The end of bookkeeping
Alex Meyer
Exit: Taking Entrepreneurship into account
Thomas Wilke
Close-up: Transatlantic advance into digital pain therapy
Alex Meyer
VenturePoland Podcast: Looking for a Better VC Partner
Julian von Fischer
Close-up: The last bastion, the intelligent production
Thomas Wilke


Horizon 2020 - the Framework Program for Research and Innovation (2014- 2020) and EFSI


42 Cap is supported by InnovFin Equity, with the financial backing of the European Union under the Horizon 2020 Financial Instruments and the European Fund for Strategic Investments ("EFSI") set up under the Investment Plan for Europe. The purpose of EFSI is to help support financing and implementing productive investments in the European Union and to ensure increased access to financing.